Page last updated: 2024-10-23

betahistine and Hospital-Acquired Condition

betahistine has been researched along with Hospital-Acquired Condition in 1 studies

Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavlyushina, EM1
Morozova, SV1

Reviews

1 review available for betahistine and Hospital-Acquired Condition

ArticleYear
[Current methods for diagnosis and treatment of iatrogenic ototoxicity].
    Vestnik otorinolaringologii, 2007, Issue:5

    Topics: Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Betahistine; Ear Diseases; Histamine Agoni

2007